The Ministry of Health (MOH) has approved Dexamethasone, a type of corticosteroid medication, as part of its treatment protocol for COVID-19 patients. Hence, the medication has been administered to inpatients and intensive care patients, who need oxygen therapy.
“There is an extensive study underway and some of its results, which were published yesterday, showed that this medication reduces the risk of deaths of COVID-19 patients, who are on ventilators in intensive care units, by 35%, and of those patients, who use oxygen but are not on ventilators, by 20%,” MOH stated.
MOH, also, highlighted that it is constantly updating its treatment protocol for COVID-19 by adding any medications that have positive impact on patients, pointing out that specialists at MOH are following up everything issued by research centers worldwide around the clock.
It is worth mentioning that ever since the beginning of COVID-19 pandemic, the Kingdom has geared up to develop treatment protocols that are constantly updated by specialized scientific committees and distributed to physicians, who are following up and treating COVID-19 patients.